Bristol-Myers Squibb (BMY) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY26 Guidance

February 5, 2026 7:00 AM EST
Get Alerts BMY Hot Sheet
Price: $63.83 -1.27%

Financial Fact:
Net Earnings: 1.22B

Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE

Bristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $1.26, $0.14 better than the analyst estimate of $1.12. Revenue for the quarter came in at $12.5 billion versus the consensus estimate of $12.24 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2026 EPS of $6.05-$6.35, versus the consensus of $6.02. Bristol-Myers Squibb sees FY2026 revenue of $46-47.5 billion, versus the consensus of $44.2 billion.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK